+91-8668442535

Antihistamines Market By Type (Prescription-based, Over-the-counter (OTC))) By Indication (Urticaria, Allergy, Dermatitis, Others) By Dosage form (Tablets, Capsules, Others) By Route of Administration (Oral, Parenteral, Others) By End-Users (Tablets, Hospitals, Specialty Clinics, Homecare, Others) By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Hospitals, Others) - Growth, Share, Opportunities & Competitive Analysis, 2016 – 2028

What is the Key Indication Diseases of Antihistamines?

Asthma and Allergic patients are increasing on a daily basis due to the air pollution. The prevalence of allergic rhinitis (A.R.) has increased dramatically over the past three decades, according to the American College of Allergy, Asthma, and Immunology (ACAAI). More than 40% of people in the U.S. and Europe are sensitive to one or more inhalant allergies. Intensifying air pollution and higher allergen sensitivity may be contributing factors to the rising prevalence of A.R. Antihistamines are useful as they address the particular cell receptors designed for histamines. Antihistamines are a class of medications that block the effects of histamine. Histamine is an immunological substance that the body's immune system releases in reaction to an allergen attack or when histamine-deficient foods are consumed. Some foods also cause an excessive amount of histamine to be produced, which results in an allergic response.

antihistamines-market

What is the Market Size of Antihistamines in term of value?

Global Antihistamines Market is projected to increase at a significant CAGR of 9.50% in the coming years. In 2021, the global Antihistamines market was valued at USD 215.9 Million and is projected to reach the value of USD 371.2 million by 2028. The demand for Antihistamines is projected to increase substantially in the coming years. It is presumed to generate revenue opportunities for the key industry players worth USD 156.26 million during the forecast period between 2022 and 2028.

Which is Major Manufacture Country for Antihistamines ?

The market share for Antihistamines in North America is the largest in the United States in 2021. The dominance is brought about by an increase in allergic rhinitis cases among children. The prevalence of allergic rhinitis among children was predicted to be around 21.1% in the year 2020. In addition, sales of nasal Antihistamines will be driven higher over the evaluation period by the rising use of nasal sprays as well as the U.S.'s well-established healthcare system.

Interesting Facts about Antihistamines Industry

  • The top 5 countries for Antihistamines exports are the United States, India, China, the United Kingdom, and Germany.
  • The top 5 importers of Antihistamines are Australia, Chile, France, Israel, and Singapore.
  • Due to rising disposable income and shifting Route of Administration lifestyles, the market for antihistamine drugs will expand. The aging population's expansion will also enhance the market's growth rate and the creation of cutting-edge drug solutions for treating allergic diseases are the major factors driving the market's growth.
  • However, the advent of generic medications and the expiration of proprietary medications may slow the market's expansion. The market for antihistamine medications will face challenges due to the absence of healthcare infrastructure in developing economies, and high implementation costs are projected to hinder the growth of the Antihistamines market over the forecast period.
  • North America region had a major share in terms of volume and value in the global Antihistamines market in 2021 and is projected to continue its dominance over the forecast period.
  • Hospitals to witness high growth during the forecast period due to increased awareness for organic products among end users across the globe.

Who are the Top 10 players/companies in Antihistamines market in term of value and volume?

The key players in the global Antihistamines market in terms of value and volume include Akorn, Incorporated (U.S.), Pfizer Inc. (U.S.), Bristol-Myers Squibb Company (U.S.), GlaxoSmithKline plc (U.K.), Novartis AG (Switzerland), Mylan N.V. (U.S.), Glenmark Pharma (India), F. Hoffmann-La Roche Ltd. (Switzerland), Teva Pharmaceutical Industries Ltd.(Israel), Sanofi (France). In order to increase their production of Antihistamines and capture a competitive market share on a global scale, these leading companies are focusing on new product advancements as well as technological innovation. Additionally, several regional and national players are investing significantly to diversify their product offerings and increase sales. For instance, in May 2021, In India, Glenmark Pharma introduced Ryaltris, a nasal spray. One of the global leaders in the respiratory sector, Glenmark was the first to release the branded version in India at a competitive price. On the other hand ,in June 2021, Through a procedure known as a partial prescription to nonprescription transition, the FDA approved the use of Bayer AG's Astepro, which is used to treat seasonal and perineal allergies, for nonprescription usage. Due to the FDA's approval, people can now acquire a safe and efficient nasal antihistamine without the help of a healthcare professional.

Who are the Top 10 Countries in the Antihistamines Market?

The major countries in the global Antihistamines market are China, India, the U.S., Canada, the U.K., Germany, France, Brazil, Japan, South Korea, and Italy. Due to the high cost of Antihistamines there as well as the rising trend of self-medication, North America is anticipated to account for a sizable portion of the global market over the forecast period. Additionally, it is predicted that the market for Antihistamines would grow due to the high prevalence of allergy disorders in this area.

Which is the Key End User Area in the Antihistamines Market?

The key Dosage Forms of Antihistamines include (Hospitals, Specialty Clinics, Homecare, and Other. It is mostly used in Hospitals. Antihistamines are mostly used to treat allergic conditions' symptoms, including itchiness, runny nose, stuffy nose, urticaria, tearful eyes, dizziness, coughing, and nausea. Sedation, reduced motor function, dry mouth and tongue, dizziness, blurred vision, constipation, and urine retention are a few of the side effects that are frequently reported after using Antihistamines. Antihistamines have several uses, including treating allergic rhinitis, conjunctivitis, urticaria, atopic dermatitis, anaphylaxis, and other conditions (angioedema, pruritus, and others). Due to the largest global prevalence of disease along with increased awareness and accessibility linked to diagnosis and treatment of diseases, allergic rhinitis and urticaria jointly accounted for more than 50% of the market share in 2020.

What are the Major Driving Factors for Antihistamines Market?

The increasing incidence of allergic responses and allergies worldwide is a significant element fueling the market's expansion for antihistamine medications. Antihistamines are used to treat seasonal allergies, motion sickness, nausea, cold and cough, and anxiety. They are also employed to treat urticaria, a skin allergy. The increase in healthcare spending, which helps to improve its infrastructure, is a crucial element influencing the growth rate of the antihistamine medicine market. The antihistamine medications market will also grow due to growing public and private activities to raise awareness about how to treat diverse allergic reactions. Additionally, the antihistamine medications market will grow due to increased disposable income and changing Route of Administration lifestyles. Along with this, the market's growth rate will be accelerated by the growing elderly population and the development of novel medication therapies for the treatment of allergic illnesses.

What are the Major Restraints for Antihistamines Market?

The key restraint of the global Antihistamines market is that the patents will hamper the market's growth rate on pharmaceuticals expiring and the release of generic versions. Furthermore, the market for antihistamine medications will face challenges due to the absence of healthcare infrastructure in developing economies and high implementation costs. Additionally, during the projected period of 2022–2029, antihistamine drug side effects such as decreased appetite, blurred vision, sleepiness, dry mouth, and others would hinder and further impede the market's growth pace.

Which Region Dominated the World Antihistamines Market?

North America is projected to be to have the largest share in the United States in 2021. The dominance is brought about by an increase in allergic rhinitis cases among children. The prevalence of allergic rhinitis among children was predicted to be around 21.1% in the year 2020. Sales of nasal Antihistamines will be driven higher over the evaluation period by the rising use of nasal sprays as well as the U.S.'s well-established healthcare system. In the East Asia area, during the course of the forecast period, nasal antihistamine sales in China are anticipated to increase at a 6.5 percent CAGR. The nasal antihistamine market is expected to increase in China in the future due to rising healthcare spending per person, supportive government policies, the introduction of new products, and rising investment for life science research.

India accounted market in the year 2020. Nasal antihistamine medication is becoming more popular among the Indian Route of Administrations for the management of allergic rhinitis. Key market players can expect to have prospects for expansion when new products are introduced in the nation at relatively cheaper prices. Generic products are chosen because they are more affordable in India, where the majority of the population pays out-of-pocket for healthcare.

Segmentation of Global Antihistamines Market-

Global Antihistamines Market – By Type

  • Prescription-based
  • Over-the-counter (OTC))

Global Antihistamines Market – By Indication

  • Urticaria
  • Allergy
  • Dermatitis
  • Others

Global Antihistamines Market – By Dosage form

  • Tablets
  • Capsules
  • Others

Global Antihistamines Market – By Route of Administration

  • Oral
  • Parenteral
  • Others

Global Antihistamines Market – By End-Users

  • Tablets
  • Hospitals
  • Specialty Clinics
  • Homecare
  • Others

Global Antihistamines Market – By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Hospitals
  • Others

Frequently asked questions about global Antihistamines industry

North America accounted for the highest share in the global Antihistamines market in terms of value as well as volume.

An increase in research and development activity is driving the market's expansion. The market for antihistamine medications will benefit from these opportunities. Along with this, an increase in drug releases and approvals will speed up the market's expansion are the major factors driving the growth of the market.

Tablets had a major share in 2021 with more than 55% of the market revenue share. Besides, capsules is projected to witness the fastest growth.

Hospitals, industry had a major share in the global market in 2021 and is projected to continue its dominance over the forecast period.

Antihistamines Market Scope

Report Attribute Details
Market Value in 2021 USD 215.9 Million
Market Value in 2028 USD 371.2 million
CAGR 9.50%
Benchmarking Year 2021
Past data 2016 – 2021
Forecast period 2022 – 2028
Choose License Type
Trusted By
Godaddy
Related Report










Published Date:  Jul 2022
Category:  Pharmaceuticals
Report ID:   59231
Report Format:   PDF
Pages:   210
Rating:    4.8 (65)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
+91-8668442535
24/7 Research Support